Ignite Creation Date:
2024-05-06 @ 4:06 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04871529
Status:
SUSPENDED
Last Update Posted:
2023-08-15
First Post:
2021-04-29
Brief Title:
Testing the Addition of an Anti-Cancer Immunotherapy Drug Avelumab to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy SWOG GAP TRIAL
Sponsor:
SWOG Cancer Research Network
Organization:
SWOG Cancer Research Network
Organization Data
Organization:
SWOG Cancer Research Network
Class:
NETWORK
Study ID:
S2011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SWOG Cancer Research Network
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |